
LipoxinA4 attenuates acute pancreatitis-associated acute lung injury by regulating AQP-5 and MMP-9 expression, anti-apoptosis and PKC/SSeCKS-mediated F-actin activation
Keywords: AP; acute pancreatitis; ALI; acute lung injury; LXs; Lipoxins; LXA4; Lipoxin A4; SIRS; systemic inflammatory response syndrome; MODS; multiple organ dysfunction syndrome; PMVECs; pulmonary microvascular endothelial cell; HPMECs; human pulmonary microvascu